Further standardization of classification of myelodysplastic syndromes
Pu, Q.
Zhonghua Nei Ke Za Zhi 42(5): 289-291
2003
ISSN/ISBN: 0578-1426 PMID: 12953719 Document Number: 558664
Document emailed within 1 workday
Related Documents
Sanz, G.F.; Morel, P. 1997: Prognostic classification in myelodysplastic syndromes Pathologie-Biologie 45(8): 617-626Haus, O.; Kotlarek-Haus, S.; Potoczek, S.; Czarnecka, M.; Duszenko, E.; Makowska, I.; Mirowska, N.; Kuliczkowski, K. 2006: Myelodysplastic syndromes according to FAB and WHO classification. Single center experience Neoplasma 53(2): 136-143
Tassin, F.; Hermanne, J.P.; Schaaf-Lafontaine, N.; Herens, C.; Thiry, A.; Paulus, J.M.; Boniver, J.; Fillet, G. 1998: Myelodysplastic syndromes: preleukemic syndromes Revue Medicale de Liege 53(6): 357-362
Dusek, J.; Bednár, B.; Dorazilová, V.; Fakan, F.; Kerekes, Z. 1990: Myelodysplastic syndromes Ceskoslovenska Patologie 26(3): 129-134
Guisasola Zulueta, M.C.; Gilsanz Fernández, C.; Tintó del Val, J.A.; García de la Fuente, A. 1986: Myelodysplastic syndromes Revista Clinica Espanola 179(4): 190-195
Sizoo, W.; Hagenbeek, A.; Löwenberg, B.; van 't Veer, M.B.; Sintnicolaas, K. 1987: Myelodysplastic syndromes Nederlands Tijdschrift Voor Geneeskunde 131(38): 1658-1661
Lishner, M.; Ravid, M. 1988: Myelodysplastic syndromes Harefuah 115(3-4): 73-76
Strebel, U. 1988: Myelodysplastic syndromes Therapeutische Umschau. Revue Therapeutique 45(2): 100-105
Carvajal Méndez, I.; García Vadillo, J.A.; Herranz Varela, A.; González Alvaro, I.; Casado Montero, F.; Castañeda Sanz, S. 1996: Polyarthritis associated with myelodysplastic syndromes Revista Clinica Espanola 196(8): 539-541
Turtureanu-Hanganu, E. 2004: The point on myelodysplastic syndromes Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 108(1): 9-16
Solary, E.; Fontenay, M.ël. 2010: Myeloproliferative/myelodysplastic syndromes La Revue du Praticien 60(10): 1413-1415
Doll, D.C.; List, A.F. 1992: Myelodysplastic syndromes: introduction Seminars in Oncology 19(1): 1-3
Tohyama, K. 2012: Treatment of myelodysplastic syndromes (MDS) Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 2): 367-372
Aviles, A.; García, L.D.; Romero, N.; Tripp, F.; González-Llaven, J. 1988: Treatment of myelodysplastic syndromes with danazol Archivos de Investigacion Medica 19(1): 73-77
Dreyfus, F.; Bouscary, D.; Melle, J.; Ribrag, V.; Guesnu, M.; Varet, B. 1995: Expression of the Evi-1 gene in myelodysplastic syndromes Leukemia 9(1): 203-205
Luraschi, A.; Saglietti, G.; Fedeli, P.; Gioria, A.; Della Vedova, A.; Ferrari, V.; Borgotti, P. 1994: Immunological indices in myelodysplastic syndromes Minerva Medica 85(4): 145-153
Sánchez Fayos, J.; Pérez Rus, G.; Outeiriño, J.; Escudero, A.; Bosch, J.M.; Calabuig, T.; Vacas, J. 1987: Myelodysplastic syndromes as preleukemic states Sangre 32(6): 715-730
Alessandrino, E.P.; Lazzarino, M.; Morra, E.; Bernasconi, P.; Colombo, A.; Bonfichi, M.; Caldera, D.; Bernasconi, C. 1990: Alpha-interferon and myelodysplastic syndromes Haematologica 75(Suppl 4): 51-55
Hellström-Lindberg, E. 1999: Treatment of adult myelodysplastic syndromes International Journal of Hematology 70(3): 141-154
Atallah, E.; Garcia-Manero, G. 2007: Use of hypomethylating agents in myelodysplastic syndromes Clinical Advances in Hematology and Oncology: H&o 5(7): 544-552